Physician profile
Devin Heinlein
NPI 1184156028
$1,461.10
in general payments reported to CMS, 2019-2025
21 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $268 · 2023: $385 · 2024: $341 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $416.29 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $153.71 | 2023-2025 | Rexulti |
| Pfizer INC. | $129.57 | 2021-2024 | |
| Lilly USA, LLC | $123.18 | 2022-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $109.25 | 2021-2024 | Trelegy Ellipta, Shingrix |
| Abbvie INC. | $101.92 | 2023-2024 | |
| Biohaven Pharmaceuticals, INC. | $95.77 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.02 | 2022 | |
| Exact Sciences Corporation | $35.59 | 2024-2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $34.96 | 2024-2025 | Inspire |
| Esperion Therapeutics, INC. | $33.10 | 2021 | |
| Bioventus LLC | $24.05 | 2025 | Durolane |
| Ascensia Diabetes Care US INC. | $18.79 | 2025 | |
| Dexcom, INC. | $18.10 | 2022 | |
| Amarin Pharma, INC. | $17.77 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.68 | 2023 | |
| Alkermes, INC. | $17.54 | 2022 | |
| Verona Pharma, INC. | $17.43 | 2025 | Ohtuvayre |
| Insulet Corporation | $16.91 | 2025 | Omnipod |
| Medtronic, INC. | $14.92 | 2024 | Minimed 780g |
| Abbott Laboratories | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Heinlein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.